Skip to content

Phillip G. Febbo, Chief Scientific & Med Officer at Veracyte, sold VCYT on Sep 4, 2026

Data as of Oct 16

▼ SELL$118K2,705 shares at $43.66Phillip G. Febbo Chief Scientific & Med OfficerVCYT Veracyte, Inc.
Watch VCYT
Traded
Sep 4, 2026
Disclosed
Sep 4, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Phillip G. Febbo, Chief Scientific & Med Officer at Veracyte, sold VCYT on Sep 4, 2026TRADEDDISCLOSED
VCYTSimilar stocks (XLV — its sector index fund), rebased to VCYT's price on the disclosure day
VCYT since disclosure
+1.4%
after the sale
Similar stocks (XLV) since disclosure
+3.1%
XLV — its sector index fund

Change in closing price from Sep 4, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLPhillip G. Febbo Chief Scientific & Med OfficerVCYT Veracyte, Inc.$446Kdisclosed Sep 4 · filed the same day

See every trade on VCYT →